Krankenhausstraße 3a, 84489 Burghausen
Surgical oncology, regional chemotherapy, electrochemotherapy, immunotherapy, hyperthermia & pain management
About the clinic
Key Competencies
Regional Chemotherapy (RCT)
Targeted administration of anticancer drugs predominantly into the blood vessels supplying the tumour area.
Benefits: Localised action and high drug concentration in the treatment zone. Scientific publication
Isolated Perfusion
Temporary isolation of the affected area from the systemic blood circulation to deliver local perfusion.
Benefits: Intensive targeted treatment of a defined region, allowing management of complex local tumours. Scientific publication
Management of Complex Tumours
Comprehensive evaluation of advanced oncological cases, including pancreatic, gastric, hepatic, and pelvic tumours.
Benefits: Tailored treatment strategies and consideration of multimodal therapeutic options. Scientific publication
Hypoxic Abdominal Perfusion
Regional treatment of the abdominal cavity in cases of peritoneal tumour dissemination.
Benefits: Targeted action within the abdominal cavity offering a regional approach for advanced disease stages. Scientific publication
Organ-Preserving Surgery
Surgical techniques focused on removing the tumour while conserving as much healthy tissue as possible.
Benefits: Preservation of organ function and acquisition of tissue samples for histological analysis. Scientific publication
Overcoming Drug Resistance
Regional methods provide alternative management options for tumours with an inadequate response to systemic chemotherapy.
Benefits: Alternative drug delivery route enabling direct local therapeutic impact. Scientific publication
Electrochemotherapy
Combining chemotherapy drugs with electrical pulses applied directly to the tumour site.
Benefits: Localised treatment suitable for selected cutaneous and subcutaneous tumour lesions. Scientific publication
Immunotherapy
Treatment aimed at boosting the body’s immune response against cancer cells.
Benefits: Option to utilise immunotherapeutic agents and combine systemic treatment with other modalities. National Cancer Institute
Hyperthermia
Controlled elevation of body temperature, either regionally or systemically.
Benefits: Targeted damage to cancer cells and increased sensitivity of certain tumours to chemotherapy or radiotherapy. National Cancer Institute
Pain Management Therapy
Comprehensive treatment for cancer-related pain management.
Benefits: Pain reduction, improved sleep, enhanced mobility, and overall support for quality of life. National Cancer Institute
Key Statistics
Core clinical metrics and published study outcomes.
Clinic Figures
Perfusions Per Year
Approximately 350 regional perfusion procedures conducted annually.
RCT Procedures Per Year
Over 525 regional chemotherapy procedures delivered annually.
Inpatient Admissions Per Year
Around 550 patient hospital admissions every year.
Inpatient Beds
33 beds allocated for inpatient treatment and clinical monitoring.
Clinical Research Data
Intra-arterial Chemotherapy
Study in head and neck tumour cases involving 97 patients. Median overall survival across patient cohorts reached 9 and 22.5 months.
Hypoxic Abdominal Perfusion
Study involving 107 patients with recurrent ovarian cancer. Median survival was 12.8 months for stage IIIC and 10.9 months for stage IV.
Isolated Thoracic Perfusion
Study in advanced pleural mesothelioma including 28 patients. Median overall survival stood at 12 months, with a median progression-free survival of 9 months.
Clinic figures provided directly by the facility. Research data cited with links to corresponding PubMed publications.
Patient Stories
Patient story: Brain tumour patient from the UK
Mark Thompson from the UK sought a second medical opinion following surgery and travelled to Germany for immunotherapy treatment. Following his course of care, he described a positive treatment outcome. His story was reported by
BBC News
Need a second opinion on a complex oncology case?
Upload medical reports, MRI/CT scans, histology results, and details of prior treatments to arrange a specialist medical evaluation.
Request treatment planThe doctor or coordinator will answer within 24-48 hours.
Patient story: Metastatic breast cancer patient from Canada
Narda Hunt from Canada travelled to Germany for several cycles of regional chemotherapy after her breast cancer metastasised to the liver. She reported a significant reduction in tumour size, allowing her to resume an active lifestyle. Her story was featured on
CTV News
Patient story: Inoperable brain tumour patient from the UK
Richard Brown from the UK travelled for treatment in Germany after receiving a diagnosis of an inoperable brain tumour. His story was covered by
BBC News
Patient stories as published in the respective independent media outlets.
